CNBX — CNBX Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.38m
- $1.56m
Annual cashflow statement for CNBX Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.19 | -3.72 | -3.71 | -0.695 | -0.314 |
| Depreciation | |||||
| Non-Cash Items | 0.545 | 1.44 | 2.96 | 0.245 | 0.04 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.064 | 0.407 | 0.474 | 0.133 | 0.103 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -2.49 | -1.68 | -0.113 | -0.244 | -0.171 |
| Capital Expenditures | -0.001 | -0.002 | 0 | -0.001 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.646 | 0.027 | 0.025 | 0.115 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | 0.645 | 0.025 | 0.025 | 0.113 | 0 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.46 | 0.39 | 0.1 | 0.028 | 0.16 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.609 | -1.27 | 0.012 | -0.103 | -0.011 |